These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24826025)

  • 41. Simultaneous transdermal extraction of glucose and lactate from human subjects by reverse iontophoresis.
    Ching TS; Connolly P
    Int J Nanomedicine; 2008; 3(2):211-23. PubMed ID: 18686780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transdermal iontophoresis: modulation of electroosmosis by polypeptide.
    Hirvonen J; Guy RH
    J Control Release; 1998 Jan; 50(1-3):283-9. PubMed ID: 9685895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous extraction of urea and glucose by reverse iontophoresis in vivo.
    Sieg A; Guy RH; Delgado-Charro MB
    Pharm Res; 2004 Oct; 21(10):1805-10. PubMed ID: 15553226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor.
    Dubey S; Perozzo R; Scapozza L; Kalia YN
    Mol Pharm; 2011 Aug; 8(4):1322-31. PubMed ID: 21696184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reverse iontophoresis: noninvasive glucose monitoring in vivo in humans.
    Rao G; Guy RH; Glikfeld P; LaCourse WR; Leung L; Tamada J; Potts RO; Azimi N
    Pharm Res; 1995 Dec; 12(12):1869-73. PubMed ID: 8786958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lithium monitoring by reverse iontophoresis in vivo.
    Leboulanger B; Aubry JM; Bondolfi G; Guy RH; Delgado-Charro MB
    Clin Chem; 2004 Nov; 50(11):2091-100. PubMed ID: 15192031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iontophoresis-based transdermal delivery systems.
    Kanikkannan N
    BioDrugs; 2002; 16(5):339-47. PubMed ID: 12408738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir.
    Xu Q; Ibrahim SA; Higuchi WI; Li SK
    Int J Pharm; 2009 Mar; 369(1-2):105-13. PubMed ID: 19041698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin.
    Abla N; Naik A; Guy RH; Kalia YN
    J Control Release; 2005 Nov; 108(2-3):319-30. PubMed ID: 16169627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
    Tratta E; Pescina S; Padula C; Santi P; Nicoli S
    Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iontophoresis in drug delivery: basic principles and applications.
    Singh P; Maibach HI
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):161-213. PubMed ID: 7600587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extraction of amino acids by reverse iontophoresis in vivo.
    Sieg A; Jeanneret F; Fathi M; Hochstrasser D; Rudaz S; Veuthey JL; Guy RH; Delgado-Charro MB
    Eur J Pharm Biopharm; 2009 May; 72(1):226-31. PubMed ID: 19347973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanistic studies of flux variability of neutral and ionic permeants during constant current dc iontophoresis with human epidermal membrane.
    Li SK; Higuchi WI; Kochambilli RP; Zhu H
    Int J Pharm; 2004 Apr; 273(1-2):9-22. PubMed ID: 15010125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Textile-based non-invasive lithium drug monitoring: A proof-of-concept study for wearable sensing.
    Sweilam MN; Cordery SF; Totti S; Velliou EG; Campagnolo P; Varcoe JR; Delgado-Charro MB; Crean C
    Biosens Bioelectron; 2020 Feb; 150():111897. PubMed ID: 31786018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of electrophoresis and electroosmosis during alternating current iontophoresis across human epidermal membrane.
    Yan G; Peck KD; Zhu H; Higuchi WI; Li SK
    J Pharm Sci; 2005 Mar; 94(3):547-58. PubMed ID: 15637683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity.
    Taveira SF; Nomizo A; Lopez RF
    J Control Release; 2009 Feb; 134(1):35-40. PubMed ID: 19047006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis.
    Hao J; Li SK
    J Pharm Sci; 2008 Feb; 97(2):893-905. PubMed ID: 17683062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reverse iontophoresis: monitoring prostaglandin E2 associated with cutaneous inflammation in vivo.
    Mize NK; Buttery M; Daddona P; Morales C; Cormier M
    Exp Dermatol; 1997 Dec; 6(6):298-302. PubMed ID: 9412817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
    Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
    Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contributions of electromigration and electroosmosis to iontophoretic drug delivery.
    Marro D; Kalia YN; Delgado-Charro MB; Guy RH
    Pharm Res; 2001 Dec; 18(12):1701-8. PubMed ID: 11785689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.